Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses

BACKGROUND: Among patients with nondialysis-dependent chronic kidney disease (NDD-CKD) and iron-deficiency anemia (IDA), ferric citrate increases hemoglobin and iron parameters and reduces serum phosphate and fibroblast growth factor 23 (FGF23), a key phosphate-regulating hormone. We conducted post...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nephrol Dial Transplant
Autors principals: Block, Geoffrey A, Pergola, Pablo E, Fishbane, Steven, Martins, Julian G, LeWinter, Robin D, Uhlig, Katrin, Neylan, John F, Chertow, Glenn M
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
ORIGINAL ARTICLES
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6603396/
https://ncbi.nlm.nih.gov/pubmed/30380116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy318
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars